Le Minh Tu Phan1,2, My-Van Tieu3, Thi-Thu Pham2, Sungbo Cho1,4. 1. Department of Electronic Engineering, Gachon University, Seongnam-si 13120, Korea. 2. School of Medicine and Pharmacy, The University of Danang, Danang 550000, Vietnam. 3. TST Trading Service Technology Co., Ltd., Hochiminh City 723000, Vietnam. 4. Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, Korea.
Abstract
Despite collaborative efforts from all countries, coronavirus disease 2019 (COVID-19) pandemic has been continuing to spread globally, forcing the world into social distancing period, making a special challenge for public healthcare system. Before vaccine widely available, the best approach to manage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is to achieve highest diagnostic accuracy by improving biosensor efficacy. For SARS-CoV-2 diagnostics, intensive attempts have been made by many scientists to ameliorate the drawback of current biosensors of SARS-CoV-2 in clinical diagnosis to offer benefits related to platform proposal, systematic analytical methods, system combination, and miniaturization. This review assesses ongoing research efforts aimed at developing integrated diagnostic tools to detect RNA viruses and their biomarkers for clinical diagnostics of SARS-CoV-2 infection and further highlights promising technology for SARS-CoV-2 specific diagnosis. The comparisons of SARS-CoV-2 biomarkers as well as their applicable biosensors in the field of clinical diagnosis were summarized to give scientists an advantage to develop superior diagnostic platforms. Furthermore, this review describes the prospects for this rapidly growing field of diagnostic research, raising further interest in analytical technology and strategic plan for future pandemics.
Despite collaborative efforts from all countries, coronavirus disease 2019 (n class="Disease">COVID-19) pandemic has been continuing to spread globally, forcing the world into social distancing period, making a special challenge for public healthcare system. Before vaccine widely available, the best approach to manage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is to achieve highest diagnostic accuracy by improving biosensor efficacy. For SARS-CoV-2 diagnostics, intensive attempts have been made by many scientists to ameliorate the drawback of current biosensors of SARS-CoV-2 in clinical diagnosis to offer benefits related to platform proposal, systematic analytical methods, system combination, and miniaturization. This review assesses ongoing research efforts aimed at developing integrated diagnostic tools to detect RNA viruses and their biomarkers for clinical diagnostics of SARS-CoV-2 infection and further highlights promising technology for SARS-CoV-2 specific diagnosis. The comparisons of SARS-CoV-2 biomarkers as well as their applicable biosensors in the field of clinical diagnosis were summarized to give scientists an advantage to develop superior diagnostic platforms. Furthermore, this review describes the prospects for this rapidly growing field of diagnostic research, raising further interest in analytical technology and strategic plan for future pandemics.
Authors: Daniel K W Chu; Yang Pan; Samuel M S Cheng; Kenrie P Y Hui; Pavithra Krishnan; Yingzhi Liu; Daisy Y M Ng; Carrie K C Wan; Peng Yang; Quanyi Wang; Malik Peiris; Leo L M Poon Journal: Clin Chem Date: 2020-04-01 Impact factor: 8.327
Authors: Kathrine McAulay; Andrew Bryan; Alexander L Greninger; Francisca Grill; Douglas Lake; Erin J Kaleta; Thomas E Grys Journal: Diagn Microbiol Infect Dis Date: 2020-08-02 Impact factor: 2.803
Authors: Mahmud Abdulkader Mahmud; Mark Spigt; Afework Mulugeta Bezabih; Geert-Jan Dinant; Roman Blanco Velasco Journal: BMC Res Notes Date: 2020-01-02
Authors: Paul R Lephart; Michael A Bachman; William LeBar; Scott McClellan; Karen Barron; Lee Schroeder; Duane W Newton Journal: Diagn Microbiol Infect Dis Date: 2020-09-03 Impact factor: 2.803